The Asia Pacific Intraoperative Neuromonitoring Market would witness market growth of 6.9% CAGR during the forecast period (2023-2030).
IONM provides real-time feedback on the functional status of nerves during surgery. This allows surgeons to continuously monitor the integrity of neural pathways, identify changes promptly, and take corrective actions to prevent potential complications such as nerve damage. In spinal surgeries, IONM is crucial in mitigating the risk of neurological complications. Monitoring techniques, such as somatosensory evoked potentials (SSEP) and motor evoked potentials (MEP), help assess the spinal cord's function, enabling surgeons to adjust their approach and minimize the risk of spinal cord injury.
In otolaryngological surgeries, particularly those involving the facial nerves, IONM monitors facial nerve function. This is vital in procedures such as acoustic neuroma resection, parotid gland surgery, and facial nerve decompression, helping preserve facial motor function. IONM is extensively used in orthopedic surgeries, especially those involving the spine and peripheral nerves. Monitoring spinal cord integrity during spinal fusion or scoliosis correction prevents neurological deficits. I
As per Invest India, in FY17, the hospital industry in India was worth $ 61.79 billion, projected to reach $ 132 billion by 2023. The growth of the hospital industry in India is associated with an increased focus on offering advanced surgical procedures. Hospitals in India are expanding their capabilities to offer neurosurgical interventions for conditions like brain tumors, aneurysms, and spinal disorders. The adoption of minimally invasive surgical techniques is rising in Indian hospitals. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.
The China market dominated the Asia Pacific Intraoperative Neuromonitoring Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $485.5 million by 2030. The Japan market is registering a CAGR of 6.2% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.5% during (2023 - 2030).
Based on Source Type, the market is segmented into Insourced Monitoring, and Outsourced Monitoring. Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCs). Based on Products & Services, the market is segmented into Services, Systems, and Accessories. Based on Application, the market is segmented into Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Others. Based on Modality, the market is segmented into Electromyography (EMG), Electroencephalography (EEG), Motor Evoked Potentials (MEPs), Somatosensory Evoked Potentials (SSEPs), Visual Evoked Potentials (VEPs), and Brainstem Auditory Evoked Potentials (BAEPs). Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
IONM provides real-time feedback on the functional status of nerves during surgery. This allows surgeons to continuously monitor the integrity of neural pathways, identify changes promptly, and take corrective actions to prevent potential complications such as nerve damage. In spinal surgeries, IONM is crucial in mitigating the risk of neurological complications. Monitoring techniques, such as somatosensory evoked potentials (SSEP) and motor evoked potentials (MEP), help assess the spinal cord's function, enabling surgeons to adjust their approach and minimize the risk of spinal cord injury.
In otolaryngological surgeries, particularly those involving the facial nerves, IONM monitors facial nerve function. This is vital in procedures such as acoustic neuroma resection, parotid gland surgery, and facial nerve decompression, helping preserve facial motor function. IONM is extensively used in orthopedic surgeries, especially those involving the spine and peripheral nerves. Monitoring spinal cord integrity during spinal fusion or scoliosis correction prevents neurological deficits. I
As per Invest India, in FY17, the hospital industry in India was worth $ 61.79 billion, projected to reach $ 132 billion by 2023. The growth of the hospital industry in India is associated with an increased focus on offering advanced surgical procedures. Hospitals in India are expanding their capabilities to offer neurosurgical interventions for conditions like brain tumors, aneurysms, and spinal disorders. The adoption of minimally invasive surgical techniques is rising in Indian hospitals. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.
The China market dominated the Asia Pacific Intraoperative Neuromonitoring Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $485.5 million by 2030. The Japan market is registering a CAGR of 6.2% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.5% during (2023 - 2030).
Based on Source Type, the market is segmented into Insourced Monitoring, and Outsourced Monitoring. Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCs). Based on Products & Services, the market is segmented into Services, Systems, and Accessories. Based on Application, the market is segmented into Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Others. Based on Modality, the market is segmented into Electromyography (EMG), Electroencephalography (EEG), Motor Evoked Potentials (MEPs), Somatosensory Evoked Potentials (SSEPs), Visual Evoked Potentials (VEPs), and Brainstem Auditory Evoked Potentials (BAEPs). Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Nihon Kohden Corporation
- inomed Medizintechnik GmbH
- Medtronic PLC
- SpecialtyCare, Inc. (Morgan Stanley)
- NeuroStyle Pte. Ltd.
- Computational Diagnostics, Inc.
- Accurate Neuromonitoring, LLC (Housatonic Partners)
- Intranerve Neuroscience Holdings, Llc
- Natus Medical Incorporated (Archimed SAS)
- Globus Medical, Inc.
Market Report Segmentation
By Source Type- Insourced Monitoring
- Outsourced Monitoring
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Services
- Systems
- Accessories
- Spinal Surgery
- Neurosurgery
- Orthopedic Surgery
- ENT Surgery
- Vascular Surgery
- Others
- Electromyography (EMG)
- Electroencephalography (EEG)
- Motor Evoked Potentials (MEPs)
- Somatosensory Evoked Potentials (SSEPs)
- Visual Evoked Potentials (VEPs)
- Brainstem Auditory Evoked Potentials (BAEPs)
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Intraoperative Neuromonitoring Market by Source Type
Chapter 5. Asia Pacific Intraoperative Neuromonitoring Market by End User
Chapter 6. Asia Pacific Intraoperative Neuromonitoring Market by Products & Services
Chapter 7. Asia Pacific Intraoperative Neuromonitoring Market by Application
Chapter 8. Asia Pacific Intraoperative Neuromonitoring Market by Modality
Chapter 9. Asia Pacific Intraoperative Neuromonitoring Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Nihon Kohden Corporation
- inomed Medizintechnik GmbH
- Medtronic PLC
- SpecialtyCare, Inc. (Morgan Stanley)
- NeuroStyle Pte. Ltd.
- Computational Diagnostics, Inc.
- Accurate Neuromonitoring, LLC (Housatonic Partners)
- Intranerve Neuroscience Holdings, Llc
- Natus Medical Incorporated (Archimed SAS)
- Globus Medical, Inc.
Methodology
LOADING...
